From Pathology to Precision Surgery: Scientific Foundations of Modern Corneal and Refractive Care
A surgeon’s credibility is built not only in the operating room, but also through study, analysis, and careful observation long before surgery begins.
Early in my career, I trained in ophthalmic pathology at the National Eye Institute under David Cogan. Later, I continued that work at Duke University with Gordon Klintworth. Together, these experiences shaped how I evaluate and treat corneal disease.
Before performing my first corneal transplant, I studied the tissues in detail. I examined them under the microscope, prepared and stained specimens, and learned how disease alters their structure.
As a result, surgery became an extension of understanding rather than a starting point.
For this reason, every clinical decision I make rests on that foundation. This page reflects the path that formed it.
The topics presented here are not academic curiosities. Instead, they connect corneal biomechanics, ocular immunology, and systemic metabolic disease in meaningful ways.
Importantly, the cornea does not exist in isolation. For example, irregular astigmatism is often treated as a refractive nuisance. In reality, it can signal subtle anatomic abnormalities, inflammatory activity, or underlying metabolic disruption.
Likewise, many metabolic diseases appear first in the cornea. These changes often emerge long before systemic symptoms develop. Recognizing them requires training in microscopic pathology, not just surface-level examination.
Throughout my work in refractive surgery, lamellar keratoplasty, anterior segment disease, metabolic pathology, and ophthalmic microscopy, one principle has guided every decision.
Surgical excellence begins with understanding disease at every scale—from molecular structure to visible anatomy.
The chapters presented here reflect a career spent linking surgical practice with rigorous pathological study. They address non-ectatic causes of irregular astigmatism, advanced laser surgery, and the corneal effects of metabolic disease.
Together, they demonstrate the range required of a complete corneal specialist. That range includes diagnosing uncommon conditions, recognizing systemic disease, and interpreting subtle patterns others may miss.
These writings are not offered as accomplishments. Instead, they provide context. They show the breadth of experience that shapes my clinical judgment and the pathology-based foundation that continues to guide my care today.
